# The Prophylactic Effect of Garlic Tablets to Prevent Nosocomial Infections in Intensive Care Unit Patients.

> **NCT06833125** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Alexandria University** · enrollment: 62 (estimated)

## Conditions studied

- Nosocomial Infection

## Interventions

- **DRUG:** Garlic powder standardized to allicin

## Key facts

- **NCT ID:** NCT06833125
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-03-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2025-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06833125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06833125, "The Prophylactic Effect of Garlic Tablets to Prevent Nosocomial Infections in Intensive Care Unit Patients.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06833125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*